PTC Industries (539006) Q4 16/17 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 16/17 earnings summary
23 Oct, 2026Executive summary
FY17 revenue from operations rose 4% to ₹99.39 crore; EBITDA margin excluding other income increased to 15% from 14%, while PAT and EPS declined YoY.
Performance was constrained by subdued markets, lower realizations from metal-price and currency movements, and production capacity used for AMTC trials and technology development.
AMTC opened in Lucknow, bringing advanced casting, machining, automation and materials capabilities together; near-term performance was expected to remain subdued until the facility reached full production.
Financial highlights
Net revenue from operations was ₹99.39 crore versus ₹95.68 crore; EBITDA was ₹16.53 crore versus ₹16.15 crore.
PAT was ₹5.86 crore versus ₹6.15 crore; EPS was ₹11.18 versus ₹11.74. Deferred tax arising on DSIR technology-program expenditure contributed to the PAT decline.
Domestic sales increased 32% to ₹27.86 crore; export sales, including incentives, fell 3% to ₹73.92 crore amid subdued European conditions.
Net cash from operations was ₹11.17 crore; fixed-asset purchases and capital advances used ₹71.59 crore during FY17.
Outlook and guidance
Short-term outlook remained modest until AMTC reached full production; commissioning was expected in FY18, with medium- to long-term prospects viewed more positively.
AMTC capacity and new technologies were expected to support growth in critical and super-critical applications, expand domestic and export opportunities, and improve operating costs.
Management expected profitability to improve 25–30% over the next 2–3 years, supported by AMTC capacity, technology and process improvements.
Government infrastructure investment, Make in India initiatives and GST were expected to support manufacturing demand, though industry growth in 2017 was expected to remain slower.
Latest events from PTC Industries
- Record exports and stronger adjusted PBT offset a 14% revenue decline.539006
Q4 13/14 - Revenue slipped 5%, while AMTC investment positioned expansion around advanced casting capabilities.539006
Q4 15/16 - Revenue declined, but margins and PAT improved as AMTC investment advanced.539006
Q4 14/15 - Export growth lifted pre-exceptional PBT 82% as expansion replaced the Bhiwadi unit.539006
Q4 12/13 - Profit rose 5% as operations recovered, with Mehsana expansion driving the next growth phase.539006
Q4 99/00 - PAT rose despite disruption as AMTC expansion moved toward commercial scale.539006
Q4 17/18 - AMTC-powered growth lifts FY19 results as expansion brings higher debt and execution risks.539006
Q4 18/19 - Lower FY21 revenue, higher EBITDA, and AMTC-led technology expansion shaped results and outlook.539006
Q4 20/21 - Record income and stronger margins met expanding capabilities, but COVID-19 clouded near-term growth.539006
Q4 19/20